Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CLCF1 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | MCCC2 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | SERPINB9 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | CTNND1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
mRNA | TAP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | TMBIM1 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | ACP6 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |